Skip to content
ChickenStockChickenStock
ResearchFilings

AI English summary of an SEC filing — figures as filed

Edwards Lifesciences logoEdwards Lifesciences EW

The company said Michael A. Mussallem informed the Board of his decision to retire as Non-Executive Chairman and director on March 26, 2024. The retirement will take effect in conjunction with the annual meeting on May 7, 2024.

8-KDeparture or Appointment of Directors or Certain OfficersFiled Period of report Summary published (UTC)

Key points

AI summary
  1. The company said Michael A. Mussallem informed the Board of his decision to retire as Non-Executive Chairman and director on March 26, 2024. The retirement will take effect in conjunction with the annual meeting on May 7, 2024.

  2. The company said Mussallem will not stand for election to the Board at the May 7, 2024 Annual Meeting 2024.

  3. Edwards Lifesciences said it expects to appoint Nicholas J. Valeriani, an independent director, as Chairman of the Board to succeed Mussallem.

  4. The company said Martha H. Marsh has reached the retirement age set forth in its Corporate Governance Guidelines and will not be nominated to stand for election to the Board at the 2024 Annual Meeting.

Summary

AI-written

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

Michael A. Mussallem to Retire as Non-Executive Chairman and Director

The company said Michael A. Mussallem informed the Board of his decision to retire as Non-Executive Chairman and director on March 26, 2024. The retirement will take effect in conjunction with the annual meeting on May 7, 2024.

Source · Based on the filing body and exhibits

Mussallem Not to Stand for Election at 2024 Annual Meeting

The company said Mussallem will not stand for election to the Board at the May 7, 2024 Annual Meeting 2024.

Source · Based on the filing body and exhibits

Nicholas J. Valeriani Expected to Be Appointed Chairman

Edwards Lifesciences said it expects to appoint Nicholas J. Valeriani, an independent director, as Chairman of the Board to succeed Mussallem.

Source · Based on the filing body and exhibits

Martha H. Marsh Not Nominated After Reaching Retirement Age

The company said Martha H. Marsh has reached the retirement age set forth in its Corporate Governance Guidelines and will not be nominated to stand for election to the Board at the 2024 Annual Meeting.

Source · Based on the filing body and exhibits

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

Source: SEC EDGAR (U.S. Securities and Exchange Commission). Item captions are the SEC's. The summary is for reference only and is not investment advice.